United-Guardian Inc
Company Profile
Business description
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
Contact
230 Marcus Boulevard
HauppaugeNY11788
USAT: +1 631 273-0900
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2025
Employees
25
Stocks News & Analysis
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
video
What does a weak Aussie dollar mean for investors?
stocks
AI stock rout: The US selloff in 4 charts
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,700.70 | 56.20 | 0.65% |
| CAC 40 | 7,872.48 | 24.89 | -0.32% |
| DAX 40 | 21,623.08 | 192.50 | 0.90% |
| Dow JONES (US) | 44,869.40 | 19.05 | 0.04% |
| FTSE 100 | 8,557.81 | 23.94 | 0.28% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,602.49 | 131.10 | -0.66% |
| Nikkei 225 | 39,414.78 | 397.91 | 1.02% |
| NZX 50 Index | 13,003.04 | 45.89 | 0.35% |
| S&P 500 | 6,048.19 | 19.51 | -0.32% |
| S&P/ASX 200 | 8,447.00 | 47.90 | 0.57% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |